Retatrutide: Product Overview Retatrutide (LY3437943) is an investigational once-weekly injectable peptide developed by Eli Lilly. It activates three hormone receptors, GLP-1, GIP and glucagon, and is being studied for obesity, type 2 diabetes and related metabolic conditions. Lilly has reported results from five Phase 3 trials. Product profile Attribute Detail Generic name Retatrutide Development code […]
Category Archives: Weight Management
Peptides, Weight Management
What Is Tirzepatide? A Plain-Language Guide to the Dual-Hormone Diabetes and Weight Medicine
24
Sep
Sep
Tirzepatide: Product Overview Tirzepatide (LY3298176) is a once-weekly injectable peptide from Eli Lilly that activates both the GIP and GLP-1 receptors. It was the first dual incretin agonist approved for clinical use. It’s sold as Mounjaro for type 2 diabetes and as Zepbound for weight management and obstructive sleep apnea. Product profile Attribute Detail Generic […]